Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Commun Biol ; 7(1): 208, 2024 Feb 20.
Artículo en Inglés | MEDLINE | ID: mdl-38379085

RESUMEN

Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer in the adult population. Late diagnosis, resistance to therapeutics and recurrence of metastatic lesions account for the highest mortality rate among kidney cancer patients. Identifying novel biomarkers for early cancer detection and elucidating the mechanisms underlying ccRCC will provide clues to treat this aggressive malignant tumor. Here, we report that the ubiquitin ligase praja2 forms a complex with-and ubiquitylates the AP2 adapter complex, contributing to receptor endocytosis and clearance. In human RCC tissues and cells, downregulation of praja2 by oncogenic miRNAs (oncomiRs) and the proteasome markedly impairs endocytosis and clearance of the epidermal growth factor receptor (EGFR), and amplifies downstream mitogenic and proliferative signaling. Restoring praja2 levels in RCC cells downregulates EGFR, rewires cancer cell metabolism and ultimately inhibits tumor cell growth and metastasis. Accordingly, genetic ablation of praja2 in mice upregulates RTKs (i.e. EGFR and VEGFR) and induces epithelial and vascular alterations in the kidney tissue.In summary, our findings identify a regulatory loop between oncomiRs and the ubiquitin proteasome system that finely controls RTKs endocytosis and clearance, positively impacting mitogenic signaling and kidney cancer growth.


Asunto(s)
Carcinoma de Células Renales , Neoplasias Renales , Adulto , Animales , Humanos , Ratones , Carcinoma de Células Renales/genética , Carcinoma de Células Renales/patología , Regulación hacia Abajo , Endocitosis , Receptores ErbB/genética , Receptores ErbB/metabolismo , Neoplasias Renales/genética , Neoplasias Renales/patología , Complejo de la Endopetidasa Proteasomal/metabolismo , Proteínas Tirosina Quinasas Receptoras/genética , Ubiquitina/metabolismo
2.
Ear Nose Throat J ; 101(5): 326-331, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32921178

RESUMEN

INTRODUCTION: The hemangioma is the most common vascular tumor, involving the head and neck in 60% of cases. It is rare in the larynx. In children, hemangiomas are more frequent on the subglottis, whereas in adults the most common site is the supraglottis. Laryngeal hemangioma with cavernous features isolated to the free edge of the vocal fold is a very rare clinical finding. We present 2 cases of glottic hemangioma. Both patients reported severe hoarseness. CASES: In the first patient, an extensive blue-purple mass was seen on the right vocal cord. The patient was posted for microlaryngeal surgery with carbon dioxide (CO2) laser. Second patient had a large, smooth, flesh-colored polypoid mass emanating from the left vocal cord. The patient was posted for microlaryngeal surgery. After 2 months, both patients showed a considerable voice improvement. DISCUSSION: Vocal cord hemangiomas are very rare, and they usually cause problem in the voice of the patient. A vascular lesion that may mimic a hemangioma may sometimes result from an organizing hematoma following a hemorrhage on the vocal cords due to voice abuse. Laryngeal hemangiomas also need to be distinguished pathologically from polypoidal vascular granulation tissue that may be produced by laryngeal biopsy, intubation, or trauma. Indirect endoscopy is enough to diagnosis. No active treatment is advised for adult laryngeal hemangiomas unless the lesions are symptomatic or show a tendency to involve other parts. There is no uniformly accepted treatment of head and neck hemangiomas. Surgical excision with laser CO2 microlaryngoscopic techniques gives satisfactory results.


Asunto(s)
Hemangioma , Neoplasias Laríngeas , Láseres de Gas , Adulto , Dióxido de Carbono , Niño , Hemangioma/diagnóstico , Hemangioma/cirugía , Humanos , Neoplasias Laríngeas/patología , Láseres de Gas/uso terapéutico , Pliegues Vocales/patología , Pliegues Vocales/cirugía
3.
Appl Immunohistochem Mol Morphol ; 28(8): 646-653, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-31855579

RESUMEN

Atypical polypoid adenomyoma (APA) is a rare uterine lesion constituted by atypical endometrioid glands, squamous morules, and myofibromatous stroma. We aimed to assess the immunophenotype of the 3 components of APA, with regard to its pathogenesis and its differential diagnosis. A systematic review was performed by searching electronic databases from their inception to January 2019 for immunohistochemical studies of APA. Thirteen studies with 145 APA cases were included. APA glands appeared analogous to atypical endometrial hyperplasia (endometrioid cytokeratins pattern, Ki67≤50%, common PTEN loss, and occasional mismatch repair deficiency); the prominent expression of hormone receptors and nuclear ß-catenin suggest that APA may be a precursor of "copy number-low," CTNNB1-mutant endometrial cancers. Morules appeared as a peculiar type of hyperdifferentiation (low KI67, nuclear ß-catenin+, CD10+, CDX2+, SATB2+, p63-, and p40-), analogous to morular metaplasia in other lesions and distinguishable immunohistochemically from both conventional squamous metaplasia and solid cancer growth. Stroma immunphenotype (low Ki67, α-smooth-muscle-actin+, h-caldesmon-, CD10-, or weak and patchy) suggested a derivation from a metaplasia of normal endometrial stroma. It was similar to that of nonatypical adenomyoma, and different from adenosarcoma (Ki67 increase and CD10+ in periglandular stroma) and myoinvasive endometrioid carcinoma (h-caldesmon+ in myometrium and periglandular fringe-like CD10 pattern).


Asunto(s)
Adenomioma/diagnóstico , Neoplasias Uterinas/diagnóstico , Adenomioma/metabolismo , Adenomioma/patología , Sesgo , Biomarcadores de Tumor/metabolismo , Femenino , Humanos , Inmunohistoquímica , Inmunofenotipificación , Antígeno Ki-67/metabolismo , Neprilisina/metabolismo , Fosfohidrolasa PTEN/genética , Fosfohidrolasa PTEN/metabolismo , Factores de Riesgo , Neoplasias Uterinas/metabolismo , Neoplasias Uterinas/patología , beta Catenina/genética , beta Catenina/metabolismo
4.
Int J Surg Pathol ; 28(8): 906-912, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32423273

RESUMEN

Primary angiosarcoma (AS) of the breast is an extremely unusual variant of breast malignancies, and its incidence is about 0.05% of all primary breast tumors. In this article, we present a rare case of a primary AS that developed in a young woman with breast implants. This case report emphasizes importance of early investigation for accurate diagnosis and proper management of the breast AS, along with a correlation of histopathologic, radiologic, and clinical findings.


Asunto(s)
Implantación de Mama/efectos adversos , Implantes de Mama/efectos adversos , Neoplasias de la Mama/etiología , Mama/patología , Hemangiosarcoma/etiología , Adulto , Biopsia con Aguja Fina , Mama/diagnóstico por imagen , Mama/cirugía , Implantación de Mama/instrumentación , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/patología , Neoplasias de la Mama/terapia , Quimioterapia Adyuvante , Femenino , Hemangiosarcoma/diagnóstico , Hemangiosarcoma/patología , Hemangiosarcoma/terapia , Humanos , Escisión del Ganglio Linfático , Imagen por Resonancia Magnética , Mastectomía , Clasificación del Tumor , Ultrasonografía Intervencional , Ultrasonografía Mamaria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA